Align Technology (ALGN) Expected to Announce Quarterly Earnings on Wednesday

Key Points

• Align Technology is set to announce its Q3 2025 earnings on October 29th, with analysts expecting earnings of $2.38 per share and revenue of approximately $980.7 million.
• The company's previous quarterly results reported an EPS of $2.49, which fell short of expectations, contributing to a 1.6% year-over-year revenue decline and a consensus rating of "Hold" from analysts.
• Align's Board of Directors recently approved a $200 million stock repurchase program, indicating confidence in the company's valuation amidst recent share price fluctuations.

Align Technology (NASDAQ:ALGN - Get Free Report) will likely be issuing its Q3 2025 results after the market closes on Wednesday, October 29th. Analysts expect the company to announce earnings of $2.38 per share and revenue of $980.7470 million for the quarter. Align Technology has set its Q3 2025 guidance at EPS.Individuals are encouraged to explore the company's upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Wednesday, October 29, 2025 at 4:30 PM ET.

Align Technology (NASDAQ:ALGN - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing the consensus estimate of $2.57 by ($0.08). Align Technology had a return on equity of 13.36% and a net margin of 11.04%.The business had revenue of $1.01 billion during the quarter, compared to analysts' expectations of $1.06 billion. During the same period in the previous year, the company posted $2.41 EPS. Align Technology's revenue for the quarter was down 1.6% on a year-over-year basis. On average, analysts expect Align Technology to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Align Technology Stock Performance

Shares of ALGN opened at $136.22 on Wednesday. The company has a 50 day moving average price of $134.63 and a 200-day moving average price of $163.04. Align Technology has a fifty-two week low of $122.00 and a fifty-two week high of $246.19. The stock has a market capitalization of $9.87 billion, a PE ratio of 22.97, a PEG ratio of 1.53 and a beta of 1.70.

Align Technology announced that its Board of Directors has authorized a stock repurchase program on Tuesday, August 5th that allows the company to repurchase $200.00 million in shares. This repurchase authorization allows the medical equipment provider to buy up to 2% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's board believes its shares are undervalued.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the stock. Zacks Research raised shares of Align Technology from a "strong sell" rating to a "hold" rating in a research report on Tuesday, September 30th. Leerink Partners lowered their price target on shares of Align Technology from $188.00 to $172.00 and set an "outperform" rating for the company in a research report on Tuesday, October 14th. Wells Fargo & Company reduced their price objective on shares of Align Technology from $246.00 to $199.00 and set an "overweight" rating for the company in a research note on Thursday, July 31st. Jefferies Financial Group reiterated a "hold" rating and set a $140.00 price objective (down previously from $215.00) on shares of Align Technology in a research note on Friday, October 10th. Finally, UBS Group reduced their price objective on shares of Align Technology from $160.00 to $155.00 and set a "neutral" rating for the company in a research note on Thursday, October 16th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $181.67.

Insider Transactions at Align Technology

In related news, CEO Joseph M. Hogan purchased 7,576 shares of the business's stock in a transaction on Friday, August 1st. The shares were acquired at an average price of $131.49 per share, for a total transaction of $996,168.24. Following the purchase, the chief executive officer owned 184,945 shares of the company's stock, valued at $24,318,418.05. This trade represents a 4.27% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.66% of the company's stock.

Institutional Trading of Align Technology

A number of hedge funds and other institutional investors have recently made changes to their positions in ALGN. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Align Technology by 4.8% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,222 shares of the medical equipment provider's stock worth $1,624,000 after acquiring an additional 469 shares during the period. Focus Partners Wealth increased its stake in shares of Align Technology by 5.2% in the first quarter. Focus Partners Wealth now owns 3,062 shares of the medical equipment provider's stock worth $486,000 after acquiring an additional 151 shares during the period. Sivia Capital Partners LLC acquired a new stake in shares of Align Technology in the second quarter worth $204,000. EverSource Wealth Advisors LLC increased its stake in shares of Align Technology by 55.7% in the second quarter. EverSource Wealth Advisors LLC now owns 531 shares of the medical equipment provider's stock worth $101,000 after acquiring an additional 190 shares during the period. Finally, First Trust Advisors LP increased its stake in shares of Align Technology by 201.7% in the second quarter. First Trust Advisors LP now owns 88,270 shares of the medical equipment provider's stock worth $16,712,000 after acquiring an additional 59,010 shares during the period. Institutional investors and hedge funds own 88.43% of the company's stock.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.